R. Baltussen

Publication List Details

Period

2000 - 2008

Number

7

Co-Authors

WHO Library Cataloguing-in-Publication Data World Health Organization. (2008)

C Ontents, R. Baltussen, T. Adam, R. Hutubessy, A. Acharya, ...

The graphic on the cover is a stylized representation of Figure 5 in Background Paper 7 showing uncertainty analysis.

Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? (2007)

Baltussen, R, Koolman, X, Shrestha, N, Bhattarai, P, Niessen, L W

Objectives To identify and weigh the various criteria for priority setting, and to assess whether a recently evaluated lung health programme in Nepal should be considered a priority in that country....

Cost effectiveness analysis of strategies for tuberculosis control in developing countries (2005)

Baltussen, R., Floyd, K., Dye, C.

OBJECTIVE: To assess the costs and health effects of tuberculosis control interventions in Africa and South East Asia in the context of the millennium development goals. DESIGN: Cost effectiveness...

Iron fortification and iron supplementation are cost-effective interventions to reduce iron deficiency in four subregions of the world (2004)

Baltussen, R., Knai, C., Sharan, M.

Iron deficiency is the most common and widespread nutritional disorder in the world, affecting millions of people in both nonindustrialized and industrialized countries. We estimated the costs,...

[Cost effectiveness of vaccination against pneumococcal bacteremia in the elderly: the results in Belgium] (2000)

Ament, A, Baltussen, R

BACKGROUND: Several studies have shown that pneumococcal vaccination of older persons would be cost-effective in preventing pneumococcal pneumonia, but evidence of clinical protection for this...

Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries (2000)

Baltussen, R, Duru, G, Rigaud-Bully, C, De Graeve, D, Ortqvist, A, ...

Pneumococcal vaccination of older persons is thought to be cost-effective in preventing pneumococcal pneumonia, but evidence of clinical protection is uncertain. Because there is better evidence of...